Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis ; volume:2 ; number:6 ; day:6 ; month:9 ; year:2000 ; pages:1-11 ; date:12.2000
Breast cancer research ; 2, Heft 6 (6.9.2000), 1-11, 12.2000
- Urheber
-
Maaroufi, Younes
- Beteiligte Personen und Organisationen
-
Lacroix, Marc
Lespagnard, Laurence
Journé, Fabrice
Larsimont, Denis
Leclercq, Guy
SpringerLink (Online service)
- DOI
-
10.1186/bcr92
- URN
-
urn:nbn:de:1111-2016032346456
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maaroufi, Younes
- Lacroix, Marc
- Lespagnard, Laurence
- Journé, Fabrice
- Larsimont, Denis
- Leclercq, Guy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers
Urokinase receptor in cancer and vascular aging : role in intracellular proteolysis and DNA repair
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers
Urokinase receptor in cancer and vascular aging : role in intracellular proteolysis and DNA repair
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers
Urokinase receptor in cancer and vascular aging : role in intracellular proteolysis and DNA repair
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers